Facilitation of memory for extinction of drug-induced conditioned reward: role of amygdala and acetylcholine.
These experiments examined the effects of posttrial peripheral and intra-amygdala injections of the cholinergic muscarinic receptor agonist oxotremorine on memory consolidation underlying extinction of amphetamine conditioned place preference (CPP) behavior. Male Long-Evans rats were initially trained and tested for an amphetamine (2 mg/kg) CPP. Rats were subsequently given limited extinction training, followed by immediate posttrial peripheral or intrabasolateral amygdala injections of oxotremorine. A second CPP test was then administered, and the amount of time spent in the previously amphetamine-paired and saline-paired apparatus compartments was recorded. Peripheral (0.07 or 0.01 mg/kg) or intra-amygdala (10 etag/0.5 microL) postextinction trial injections of oxotremorine facilitated CPP extinction. Oxotremorine injections that were delayed 2 h posttrial training did not enhance CPP extinction, indicating a time-dependent effect of the drug on memory consolidation processes. The findings indicate that memory consolidation for extinction of approach behavior to environmental stimuli previously paired with drug reward can be facilitated by posttrial peripheral or intrabasolateral amygdala administration of a cholinergic agonist.
Department of Psychology, Yale University, New Haven, Connecticut 06520, USA.
Jason P
JP
Schroeder
Mark G
MG
Packard
D000109:Acetylcholine / Q000378:metabolism; D000679:Amygdala / Q000187:drug effects* / Q000378:metabolism; D000704:Analysis of Variance; D000818:Animals; D003214:Conditioning, Classical / Q000187:drug effects* / Q000502:physiology; D003913:Dextroamphetamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004777:Environment; D005108:Extinction, Psychological / Q000187:drug effects* / Q000502:physiology; D007274:Injections, Intraperitoneal; D008297:Male; D008568:Memory / Q000187:drug effects* / Q000502:physiology; D008845:Microinjections; D018721:Muscarinic Agonists / Q000008:administration & dosage*; D010095:Oxotremorine / Q000008:administration & dosage*; D051381:Rats; D020318:Rats, Long-Evans; D012054:Reinforcement, Psychology
D018721:Muscarinic Agonists; D010095:Oxotremorine; D000109:Acetylcholine; D003913:Dextroamphetamine